Is Guillain-Barrè syndrome triggered by SARS-CoV-2? Case report and literature review
Tóm tắt
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the infectious agent responsible for coronavirus disease 2019 (COVID-19). Respiratory and gastrointestinal manifestations of SARS-CoV-2 are well described, less defined is the clinical neurological spectrum of COVID-19. We reported a case of COVID-19 patient with acute monophasic Guillain-Barré syndrome (GBS), and a literature review on the SARS-CoV-2 and GBS etiological correlation. A 68 years-old man presented to the emergency department with symptoms of acute progressive symmetric ascending flaccid tetraparesis. Oropharyngeal swab for SARS-CoV-2 tested positive. Neurological examination showed bifacial nerve palsy and distal muscular weakness of lower limbs. The cerebrospinal fluid assessment showed an albuminocytologic dissociation. Electrophysiological studies showed delayed distal latencies and absent F waves in early course. A diagnosis of Acute Inflammatory Demyelinating Polyradiculoneuropathy (AIDP) subtype of GBS was then made. Neurological manifestations of COVID-19 are still under study. The case we described of GBS in COVID-19 patient adds to those already reported in the literature, in support of SARS-CoV-2 triggers GBS. COVID-19 associated neurological clinic should probably be seen not as a corollary of classic respiratory and gastrointestinal symptoms, but as SARS-CoV-2-related standalone clinical entities. To date, it is essential for all Specialists, clinicians and surgeons, to direct attention towards the study of this virus, to better clarify the spectrum of its neurological manifestations.
Tài liệu tham khảo
WHO Director-General’s opening remarks at the media briefing on COVID-19 - 11 March 2020. https://www.who.int/dg/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020
Track reported cases of COVID-19
Vetter P, Lan Vu D, L’Huillier AG, Schibler M, Kaiser L, Jacquerioz F (2020) Clinical features of covid-19. BMJ. 369:m1470. https://doi.org/10.1136/bmj.m1470
Needham EJ, Chou SH-Y, Coles AJ, Menon DK (2020) Neurological implications of COVID-19 infections. Neurocrit Care 32:667–671. https://doi.org/10.1007/s12028-020-00978-4
Ahmad I, Rathore FA (2020) Neurological manifestations and complications of COVID-19: a literature review. J Clin Neurosci 77:8–12. https://doi.org/10.1016/j.jocn.2020.05.017
Cosi V, Versino M (2006) Guillain-Barré syndrome. Neurol Sci 27:S47–S51. https://doi.org/10.1007/s10072-006-0548-4
De Andrade da Silva R, Carvalho Cremaschi R, Rebello Pinho JR, Bosco de Oliveira J, Morgadinho Coelho F (2019) Guillain–Barré syndrome—the challenge of unrecognized triggers. Neurol Sci 40(11):2403–2404. https://doi.org/10.1007/s10072-019-03926-z
Guillain-Barré Syndrome Study Group (2000) Guillain-Barré syndrome: an Italian multicentre case-control study. Neurol Sci 21(4):229–234. https://doi.org/10.1007/s100720070081
Van Doorn PA, Ruts L, Jacobs BC (2008) Clinical features, pathogenesis, and treatment of Guillain-Barrè syndrome. Lancet Neurol 7:939–950. https://doi.org/10.1016/S1474-4422(08)70215-1
Ottaviani D, Boso F, Tranquillini E, Gapeni I, Pedrotti G, Cozzio S, Guarrera GM, Giometto B (2020) Early Guillain-Barré syndrome in coronavirus disease 2019 (COVID-19): a case report from an Italian COVID-hospital. Neurol Sci. https://doi.org/10.1007/s10072-020-04449-8
Zhao H, Shen D, Zhou H, Liu J, Chen S (2020) Guillain-Barré syndrome associated with SARS-CoV-2 infection: causality or coincidence? Lancet Neurol 19:383–384. https://doi.org/10.1016/S1474-4422(20)30109-5
Sedaghata Z, Karimib N (2020) Guillain Barre syndrome associated with COVID-19 infection: a case report. J Clin Neurosci 76:233–235. https://doi.org/10.1016/j.jocn.2020.04.062
Alberti P, Beretta S, Piatti M, Karantzoulis A, Piatti ML, Santoro P, Viganò M, Giovannelli G, Pirro F, Montisano DA, Appollonio I, Ferrarese C (2020) Guillain-Barré syndrome related to COVID-19 infection. Neurol Neuroimmunol Neuroinflamm 29:7. https://doi.org/10.1212/NXI.0000000000000741
Padroni M, Mastrangelo V, Asioli GM, Pavolucci L, Abu-Rumeileh S, Piscaglia MG, Querzani P, Callegarini C, Foschi M (2020) Guillain-Barrè syndrome following COVID-19: new infection, old complication? J Neurol 267:1877–1879. https://doi.org/10.1007/s00415-020-09849-6
El Otmani H, El Moutawakil B, Rafai M-A, El Benna N, El Kettani C, Soussi M, El Mdaghri N, Barrou H, Afif H (2020) Covid-19 and Guillain-Barré syndrome: more than a coincidence! Rev Neurol (Paris) 176:518–519. https://doi.org/10.1016/j.neurol.2020.04.007
Coen M, Jeanson G, Culebras Almeida LA, Hübers A, Stierlin F, Najjar I, Ongaro M, Moulin K, Makrygianni M, Leemann B, Kronig I, Bertrand J, Reny JL, Schibler M, Serratrice J (2020) Guillain-Barré syndrome as a complication of SARS-CoV-2 infection. Brain Behav Immun S0889-1591:30698–3069X. https://doi.org/10.1016/j.bbi.2020.04.074
Toscano G, Palmerini F, Ravaglia S, Ruiz L, Invernizzi P, Cuzzoni MG, Franciotta D, Baldanti F, Daturi R, Postorino P, Cavallini A, Micieli G (2020) Guillain-Barré syndrome associated with SARS-CoV-2. N Engl J Med 382:2574–2576. https://doi.org/10.1056/NEJMc2009191
Scheidl E, Diez Canseco D, Hadji-Naumov A, Bereznai (2020) Guillain-Barre syndrome during SARS-CoV-2 pandemic: a case report and review of recent literature. JPNS. 25:204–207. https://doi.org/10.1111/jns.12382
Riva N, Russo T, Falzone YM, Strollo M, Amadio S, Del Carro U, Locatelli M, Filippi M, Fazio R (2020) Post-infectious Guillain–Barré syndrome related to SARS-CoV-2 infection: a case report. J Neurol 26:1–3. https://doi.org/10.1007/s00415-020-09907-z
Assini A, Benedetti L, Di Maio S, Schirinzi E, Del Sette M (2020) New clinical manifestation of COVID-19 related Guillain-Barrè syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci. https://doi.org/10.1007/s10072-020-04484-5
Bigaut K, Mallaret M, Baloglu S, Nemoz B, Morand P, Baicry F, Godon A, Voulleminot P, Kremer L, Chanson J-B, De Seze J (2020) Guillain-Barrè syndrome related to SARS-CoV-2 infection. https://doi.org/10.1212/NXI.0000000000000785
Romero-Sánchez CM, Díaz-Maroto I, Fernández-Díaz E, Sánchez-Larsen A, Layos-Romero A, García-García J, González E, Redondo-Peñas I, Perona-Moratalla AB, Del Valle-Pérez JA, Gracia-Gil J, Rojas-Bartolomé L, Feria-Vilar I, Monteagudo M, Palao M, Palazón-García E, Alcahut-Rodríguez C, Sopelana-Garay D, Moreno Y, Ahmad J, Segura T (2020) Neurologic manifestations in hospitalized patients with COVID-19: the ALBACOVID registry. Neurology:10.1212/WNL.0000000000009937. https://doi.org/10.1212/WNL.0000000000009937
Chan JC, Ebadi H, Sarna JR (2020) Guillain-Barré syndrome with facial diplegia related to SARS-CoV-2 infection. Can J Neurol Sci:1–3. https://doi.org/10.1017/cjn.2020.106
Baig AM, Khaleeq A, Ali U, Syeda H (2020) Evidence of the COVID-19 virus targeting the CNS: tissue distribution, host-virus interaction, and proposed neurotropic mechanisms. ACS Chem Neurosci:995–998. https://doi.org/10.1021/acschemneuro.0c00122
Fukae J, Tsugawa J, Ouma S, Umezu T, Kusunoki S, Tsuboi Y (2016) Guillain-Barrè and Miller Fisher syndromes in patients with anti-hepatitis E virus antibody: a hospital-based survey in Japan. Neurol Sci 37(11):1849–1851. https://doi.org/10.1007/s10072-016-2644-4
Filia A, Lauria G (2014) Guillain-Barrè syndrome following measles infection: case report and review of the literature. Neurol Sci 35(12):2017–2018. https://doi.org/10.1007/s10072-014-1841-2
Cao-Lormeau VM, Blake A, Mons S, Lastère S, Roche C, Vanhomwegen J, Ghawché F (2016) Guillain-Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study. Lancet. 387:1531–1539. https://doi.org/10.1016/S0140-6736(16)00562-6
Virani A, Rabold E, Hanson T, Haag A, Elrufay R, Cheema T, Balaan M, Bhanotc N (2020) Guillain-Barré syndrome associated with SARS-CoV-2 infection. IDCases. 20:e00771. https://doi.org/10.1016/j.idcr.2020.e00771
Camdessanche JP, Morel J, Pozzetto B, Paul S, Tholance Y, Botelho-Nevers E (2020) COVID-19 may induce Guillain-Barré syndrome. Rev Neurol (Paris) S0035-3787:30522–30521. https://doi.org/10.1016/j.neurol.2020.04.003